（2020年7月30日，/HRoot.com/）近日，據瀚納仕的最新研究顯示，在疫情期間，新加坡的生命科學領域人才需求穩定。
研究發現，盡管很多組織在此時可能不會擴大團隊規模，但他們仍保持著現有的團隊優勢，從而保持對替代招聘的穩定需求。作爲創新和研發中心，當前新加坡市場和企業的新入局者也有招聘需求，希望擴大其在亞洲的業務和聲譽。
分析發現，新冠疫情危機迫使許多組織在最短時間內無法適應環境，從而使一些組織難以在當前的競爭格局中找到立足之地。這導致更多公司將重點轉移到有助于應對疫情的産品，服務、設施和分銷渠道。由于缺乏尋求銷售人員的渠道和需求，生命科學中的商業銷售職能受到新冠疫情影響*大的部門之一。
瀚納仕表示，由于許多企業將重點轉向新冠疫情相關産品和服務，加上供應鏈和物流的嚴重中斷，使新加坡的許多生命科學組織在持續的經濟不確定性中處于劣勢。盡管如此，該行業的前景仍然樂觀，資金充足，有更多的大公司和投資者進入當地市場，以利用城市提供的准入機會、穩定和商業支持。
瀚納仕補充表示，隨著越來越多的企業恢複其年度招聘和擴張計劃，就業市場正在呈現中期複蘇。生命科學投資公司也繼續在新加坡擴大範圍。
盡管就業機會增加，但生命科學候選市場仍然“人才短缺”。市場上越來越多的裁員也導致湧入了一批“不一定合適的候選人”。瀚納仕表示，人力資源或人才培養團隊需要更多時間來篩選潛在候選人。這種趨勢已導致更多組織探索與外部機構合作，以在這個充滿挑戰的市場中進行招聘。
瀚納仕新加坡區域總監Grant Torrens表示：“雖然生命科學領域肯定會面臨挑戰，但新加坡穩定的經濟和監管環境是未來光明前景的有力指標。”
Torrens表示：“考慮到當前疫情導致的不穩定以及該行業的人才緊縮，瀚納仕建議希望招聘頂尖人才的組織擴大招聘標准，以充分利用當前的候選人市場。他們還可以通過專注于改善雇主品牌，提供低成本、高價值的福利（如靈活和遠程工作），著重于生産力（而不是工時）並促進工作與生活的平衡，來增強其人才吸引戰略。”
SINGAPORE – LIFE SCIENCES SECTOR SEES STEADY DEMAND DESPITE CHALLENGES: HAYS
(Jul.30, 2020, /staffingindustry.com/)Singapore’s life sciences sector found steady demand amid the pandemic, according to new research from Hays.
The research found that while organisations may not be expanding their teams at this time, they are still holding up their current team strengths, leading to a steady demand for replacement hiring. There has also been hiring demand from new entrants in the market and businesses looking to expand their Asian presence owing to Singapore’s reputation of being a hub for innovation and research and development
The analysis found that the Covid-19 crisis has forced many organisations to adjust to disruptions within the shortest time available, causing some to struggle to find their footing in the present competitive landscape. This has led to more companies shifting their focus towards products, services, facilities and distribution channels that can aid in the pandemic response. Commercial sales functions within the life sciences have been amongst the most impacted by the pandemic, owing to the lack of access and demand for salespeople.
The shift of focus to Covid-19 related products and services coupled with significant disruptions to supply chain and logistics has put many life sciences organisations in Singapore on the backfoot amidst ongoing economic uncertainty, according to Hays. But despite this, the outlook for the sector remains buoyant and well financed, with more big players and investors making their entrance into the local market to capitalise on the access, stability and business support the city offers.
Hays added that the job market is showing a mid-year recovery as more businesses get back on track with their annual hiring and expansion plans. Life science investment companies also continue to set up shop in Singapore.
Despite increasing opportunities, the life sciences candidate market remains ‘talent short’. The increasing number of redundancies in the market has also led to an influx of candidates who “may not necessarily be the right fit.” Hays adds that more time required for HR or talent acquisition teams to shortlist a potential candidate. This trend has led to more organisations exploring working with external agencies to hire in this challenging market.
Grant Torrens, Regional Director of Hays Singapore said, “While the life sciences sector is certainly seeing its share of challenges, Singapore’s stable economy and regulatory environment are strong indicators of a bright future ahead.”
“Taking into consideration the ongoing pandemic-led instability as well as talent crunch in the sector, organisations looking to hire top talent are advised to broaden their hiring criteria to take full advantage of the current candidate market. They can also strengthen their talent attraction strategies by focusing their energies on improving their employer branding and offering low-cost yet high-value benefits like flexible and remote working, focusing on productivity (rather than hours) and promoting work-life balance,” Torrens said.